COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.
Diabetes Metab Syndr
; 15(5): 102231, 2021.
Article
in English
| MEDLINE | ID: covidwho-1333363
ABSTRACT
BACKGROUND AND AIM:
This review aims to report the current status of COVID-19 among people with diabetes, newly diagnosed diabetes, diabetic ketoacidosis, and programmatic efforts including vaccinations.METHODS:
We conducted a literature search using PubMed, Google, and Scopus until July 15, 2021.RESULTS:
In Saudi Arabia, most studies have reported diabetes as one of the highly prevalent comorbidities among patients with COVID-19. Currently, there are limited studies from Saudi Arabia on the newly diagnosed diabetes and diabetic ketoacidosis caused by COVID-19. The Saudi ministry has taken several measures to control the impact of COVID-19 among people with diabetes, including comprehensive guidelines and prioritized vaccinations. During the COVID-19 pandemic, the use of telehealth services dramatically increased in diabetes clinics in Saudi Arabia.CONCLUSIONS:
Focused and evidence-based interventions are essential to control the impact of COVID-19 among people with diabetes.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Complications
/
COVID-19
Type of study:
Observational study
/
Reviews
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Diabetes Metab Syndr
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS